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Rif1 S-acylation mediates DNA double-strand break
repair at the inner nuclear membrane
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Dominique Klein1, David Shore 3, Nicolas H. Thomä 1 & Ulrich Rass 1,6
Rif1 is involved in telomere homeostasis, DNA replication timing, and DNA double-strand
break (DSB) repair pathway choice from yeast to human. The molecular mechanisms that
enable Rif1 to fulﬁll its diverse roles remain to be determined. Here, we demonstrate that Rif1
is S-acylated within its conserved N-terminal domain at cysteine residues C466 and C473 by
the DHHC family palmitoyl acyltransferase Pfa4. Rif1 S-acylation facilitates the accumulation
of Rif1 at DSBs, the attenuation of DNA end-resection, and DSB repair by non-homologous
end-joining (NHEJ). These ﬁndings identify S-acylation as a posttranslational modiﬁcation
regulating DNA repair. S-acylated Rif1 mounts a localized DNA-damage response proximal to
the inner nuclear membrane, revealing a mechanism of compartmentalized DSB repair
pathway choice by sequestration of a fatty acylated repair factor at the inner nuclear
membrane.
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R if1 (Rap1-interacting factor 1) supports diverse biologicalfunctions. First identiﬁed in Saccharomyces cerevisiae as atelomere-binding protein, Rif1 regulates telomere length by
counteracting telomerase recruitment and attenuates DNA end-
resection at dysfunctional telomeres1. These activities depend on
telomere recruitment by Rap1, mediated by two Rif1 C-terminal
regions, the RBM (Rap1-binding motif) and CTD (C-terminal
domain), and a conserved N-terminal domain with intrinsic
DNA-binding activity known as the HOOK domain2–4. Coop-
erative binding of Rif1 to DNA ends produces a protective pro-
tein sheath, which excludes DNA end-processing factors
including telomerase and the DNA end-resection machinery1,3.
Rif1 also serves as a regulator of DNA replication origins, a role
that is conserved from yeast to human5–9. RVxF/SILK motifs
mediate interactions between Rif1 orthologs and protein phos-
phatase 1 (PP1)1. Rif1 targets PP1 to replication origins, leading
to removal of activating phosphorylations on components of the
replication machinery, locally attenuating origin ﬁring and
modulating replication timing globally10–15.
In recent years, Rif1 has emerged as a critical regulator of DSB
repair pathway choice1,16–28. In mammalian cells, the
RIF1–53BP1 axis antagonizes BRCA1-CtIP-mediated 5′-DNA
end-resection, a process that exposes 3′-DNA overhangs for
homologous recombination (HR)-dependent DSB repair. Thus,
RIF1 helps stabilize DSB ends, promoting repair by re-ligation
along the NHEJ repair pathway. The conserved N-terminal part
of Rif1 plays a crucial role in attenuating DNA end-resection
from yeast to human1,3,18, and in yeast, the protective encapsu-
lation of DNA by the HOOK domain provides a mechanistic
rationale for this Rif1 activity1.
Posttranslational modiﬁcations have been implicated in the
regulation of Rif1 functions. For example, phosphorylation of
Rif1 close to the RVxF/SILK PP1-binding sites disrupts Rif1-
PP1 interactions, leading to the activation of Rif1-repressed
replication origins10–12. RIF1 ubiquitination and SUMOylation
are required for the timely dissociation of 53BP1-RIF1 com-
plexes from DNA damage, access of BRCA1-CtIP, and DSB
repair by HR29,30. Rif1 S-acylation has been detected in budding
yeast31. Pfa4 (protein fatty acyltransferase 4), a member of the
evolutionary conserved DHHC (aspartate–histidine–histidine–
cysteine) family of protein acyltransferases32 promotes Rif1
S-acylation at as-yet unmapped sites33. S-acylation, pre-
dominantly by covalent attachment of 16-carbon fatty acid
palmitate moieties to cysteine residues by thioester linkage,
increases the interactions of proteins with cellular membranes
by providing membrane anchors. Consequently, S-acylation can
affect protein localization, stability, and activity34,35. Loss of
Pfa4 was shown to lead to decreased Rif1-nuclear membrane
interactions and an increase in nuclear-luminal Rif1 at the
expense of Rif1 at the nuclear periphery33. The nuclear per-
iphery contains heterochromatin and yeast telomeres36, and the
redistribution of Rif1 in absence of Pfa4 correlated with tran-
scriptional changes of heterochromatic and telomeric genes33.
On the other hand, Rif1 telomere occupancy and the ability of
Rif1 to maintain telomere length were unaffected upon deletion
of PFA4 (ref. 33). Since Pfa4 is also dispensable for the ability of
Rif1 to regulate origin ﬁring8, the physiological roles of Rif1 S-
acylation remain to be fully elucidated33,37.
Here, we show that Pfa4-dependent S-acylation of Rif1 pro-
motes the attenuation of DNA end-resection and DSB repair by
NHEJ, implicating protein S-palmitoylation in DNA repair.
Mapping and mutating Rif1 S-acylation acceptor sites, we ﬁnd
that fatty acylation enables a localized DNA-damage response at
the nuclear membrane and reveal a mechanism of compart-
mentalized DSB repair pathway choice.
Results
The palmitoyl acyltransferase Pfa4 promotes NHEJ. Rif1 fulﬁlls
an evolutionarily conserved function in DSB repair pathway
choice, stabilizing DNA ends and promoting DSB repair by
simple re-ligation along the NHEJ pathway3,16–20. We hypothe-
sized that if the reported Pfa4-dependent S-acylation of S. cere-
visiae Rif1 (ref. 33) is important for Rif1’s role in NHEJ, deletion
of PFA4, like a deletion of RIF1, should decrease the efﬁciency of
NHEJ. To test this, we used a reporter strain containing an
inducible DSB at the MAT locus that can only be repaired by
NHEJ38 (see Fig. 1a for details). As expected, cell viability upon
DSB induction was fully dependent on core NHEJ factor Ku70
(Fig. 1b). Consistent with previous results3, deleting RIF1 led to a
marked decrease in cell viability by ~40% after 2 h of transient
DSB induction, reﬂecting compromised NHEJ in absence of Rif1.
Under the same conditions, loss of palmitoyl transferase Pfa4
caused a comparable decrease in cell survival (Fig. 1b), impli-
cating Pfa4 in NHEJ. In line with previous observations33, loss of
Pfa4 did not affect Rif1 protein levels (Supplementary Fig. 1a).
Interestingly, the NHEJ defect of pfa4Δ cells was not aggravated
by the deletion of RIF1 (Fig. 1b). Disruption of NHEJ in yeast
results in increased cell survival during chronic exposure to
radiomimetic drugs such as Zeocin, consistent with HR being the
more optimal pathway of DNA repair under these conditions39.
We have shown previously that cells deleted for RIF1 exhibit a
~2-fold increase in Zeocin resistance compared to wild-type
control cells3. A similar increase in survival upon Zeocin expo-
sure was observed for cells deleted for PFA4, but not cells deleted
for any of the other six palmitoyl-transferases present in budding
yeast (Supplementary Fig. 1b). Furthermore, Zeocin resistance
levels of rif1Δ pfa4Δ double-mutant cells were no greater than
those of rif1Δ or pfa4Δ single mutant cells (Fig. 1c). These results
suggest that Rif1 and Pfa4 may act jointly to facilitate NHEJ.
Across organisms, Rif1 promotes DSB repair by NHEJ through
the attenuation of DNA end-resection1. To test whether Pfa4
impacts on DNA end-resection, we measured the accumulation of
single-stranded DNA (ssDNA) at the induced DSB at the MAT
locus using a qPCR-based method40 (see Fig. 1a for details).
Strikingly, loss of Pfa4 was associated with a ~2-fold increase in
ssDNA (2 h time-point) after DSB induction, phenocopying the
effect caused by loss of Rif1, while the combined loss of Rif1 and
Pfa4 did not increase ssDNA accumulation further (Fig. 1d). Thus,
like Rif1, Pfa4 is required to prevent hyper-resection at DSBs.
These ﬁndings suggest that protein S-palmitoylation is
important for NHEJ efﬁciency in yeast, and implicate Pfa4 and
Rif1 in a common pathway of DSB repair pathway choice.
Rif1-mediated NHEJ is dependent on residues C466 and C473.
Having observed an epistatic defect in NHEJ efﬁciency after
disruption of RIF1 and/or PFA4, we sought evidence that Pfa4
acts through Rif1 to promote NHEJ. To identify sites of potential
Rif1 S-acylation involved in NHEJ, we performed a mutational
analysis of Rif1 and screened for compromised NHEJ efﬁciency.
This analysis was based on two assumptions: ﬁrst, relevant S-
acylated cysteine residues must be contained within the N-
terminal domain of Rif1 (residues 1–1322, hereafter referred to as
Rif1NTD for Rif1 N-terminal domain). This region of Rif1 was
shown to be required and sufﬁcient for promoting NHEJ, with
cells expressing Rif1NTD from the endogenous RIF1 locus being as
effective in promoting NHEJ as cells expressing full-length Rif1
(ref. 3) (see also Supplementary Fig. 2a). Secondly, S-acylation
must occur on cysteines likely to be surface-exposed, which we
identiﬁed using the available crystal structure information for
Rif1NTD3. Of 19 cysteines present in Rif1, 14 are contained within
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Rif1NTD, with C466, C473, C906, C1022, and C1089 being
surface-exposed (Fig. 2a). In addition, we included in the analysis
C71 and C1292, for which structural information is not available.
Notably, in silico analysis using Swisspalm/CSS-Palm41 predicted
one of the cysteines that we selected, C466, as a residue of
potential Rif1 S-palmitoylation (Supplementary Fig. 2b).
We grouped Rif1NTD residues C906, C1022, C1089, and C1292
(referred to as cluster 1), and C71, C466, and C473 (cluster 2) to
facilitate the mutational analyses (Fig. 2a), targeting endogenous
RIF1 for alanine substitutions of all cysteines in cluster 1 and 2,
alone and in combination, in the NHEJ reporter strain (see
Fig. 1a). Single or combined alanine substitutions within cluster 1
had no effect on NHEJ efﬁciency as assessed by cell survival after
DSB induction (Fig. 2b). In contrast, cluster 2 mutants Rif1
C71A/C466A/C473A and Rif1 C466A/C473A were associated
with reduced survival after DSB induction, phenocopying RIF1
(Fig. 2b) and/or PFA4 (Fig. 1b) deletions. Single-site mutants Rif1
C466A or C473A had no effect on cell survival after DSB
formation. Consistent results were obtained upon chronic
exposure of cells to Zeocin, where the rif1 C466A/C473A allele
led to increased Zeocin resistance, similar to what is observed for
rif1Δ, pfa4Δ, or rif1Δ pfa4Δ cells, while the rif1 C466A and rif1
C473A single-mutation alleles had no effect (Fig. 2c, see also
Fig. 1c). All cluster 2 mutations had little or no impact on protein
stability (Supplementary Fig. 2c). These results indicate an
impairment of NHEJ by combined, but not individual loss of
potential Rif1 S-acylation sites C466 and C473.
Rif1 DSB end-protection and targeting requires C466 and
C473. To assess the functional consequences of mutating
potential Rif1 S-acylation sites C466 and C473, we measured
DNA end-resection using the inducible DSB at the MAT locus.
Compared to cells expressing wild-type Rif1NTD, cells expressing
Rif1NTD C466A/C473A, but not those expressing Rif1NTD with a
single C466A mutation, showed a ~2-fold increase of ssDNA
accumulation (2 h time-point) (Fig. 3a, see also Supplementary
Fig. 3a for NHEJ efﬁciency). This was not due to changes in
protein levels (Supplementary Fig. 3b), nor a general loss of
protein function since the Rif1NTD C466A/C473A mutant closely
reﬂected the behavior of wild-type Rif1NTD in suppressing repli-
cation origin ﬁring12 (Supplementary Fig. 3c). The observed DSB
hyper-resection associated with Rif1NTD C466A/C473A was
comparable in cells deleted for RIF1 or deleted for PFA4, and in
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Fig. 1 The palmitoyl acyltransferase Pfa4 promotes NHEJ. a Schematic representation of S. cerevisiae chromosome III harboring a MATα HO-endonuclease
cut site. Upon DSB formation by induction of HO endonuclease, cell survival is possible by NHEJ while DNA end-resection leads to cell death due to lack of
an HR repair template (hmlΔ/hmrΔ). ssDNA formation progressively inactivates the annotated AluI restriction sites, leading to increased qPCR product
yield (primers indicated in red), providing a quantitative read-out for DNA end-resection. b NHEJ efﬁciency for the indicated strains measured by cell
viability following 2 or 4 h of HO-endonuclease induction. Data are presented as mean values ± s.e.m. (n= 6 independent experiments). c Cell viability in
the presence of Zeocin (70 μg/ml). Data are presented as mean values ± s.e.m. (n= 6 independent experiments). d ssDNA formed by DNA end-resection
as determined by qPCR. Data are presented as mean values ± s.e.m. (n= 6 independent experiments). PE, plating efﬁciency; PET0, plating efﬁciency
without HO-endonuclease induction; PERIF1, plating efﬁciency of RIF1 wild-type reference strain; WT, wild-type. For statistical analysis, one-way analysis of
variance (Anova) and a post-hoc Tukey–Kramer multiple comparison test was performed, comparing wild-type to the indicated mutants. See also
Supplementary Fig. 1. Source data are provided as a Source Data ﬁle
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10349-z ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2535 | https://doi.org/10.1038/s41467-019-10349-z | www.nature.com/naturecommunications 3
cells expressing Rif1NTD DNA-binding site mutant K437E/
K563E/K570E (referred to as HOOK mutant)3 (Fig. 3a). Thus,
like protective encapsulation of DNA ends by the HOOK domain,
potential Rif1 S-acylation sites C466 and C473 are essential for
Rif1-mediated DNA end-protection.
To analyze Rif1NTD occupancy at DSBs, we performed
chromatin immunoprecipitation (ChIP) at the MAT DSB. As
expected, Rif1NTD accumulated following cut induction, but
occupancy compared to wild-type was reduced by ~40% (4 h
time-point, 0.3 kb from DSB) when potential Rif1 S-acylation
sites C466 and C473 were mutated, or when PFA4 was deleted
(Fig. 3b). Consistent with previous results3, a similar loss of
Rif1NTD from the DSB was observed upon introduction of the
DNA-binding site HOOK mutation (Fig. 3b), and combining the
HOOK and C466A/C473A mutations reduced Rif1NTD occu-
pancy at DSBs further (Supplementary Fig. 3d, e). As shown in
Fig. 2a, C466 and C473 are pointing away from the DNA-binding
site, mapping to the convex surface of the HOOK domain. To
rule out the possibility that the C466A/C473A mutation might
disrupt DSB occupancy and cause NHEJ deﬁciency by disturbing
the DNA-binding site at the concave surface of the HOOK
domain, we puriﬁed Rif1 constructs (spanning residues
100–1322) with and without the C466A/C473A and HOOK
mutations (Fig. 3c) to compare their DNA-binding activity using
electromobility shift assays (EMSAs). As shown previously3, the
Rif1 DNA-binding site HOOK mutant K437E/K563E/K570E was
impaired in its ability to retard the DNA substrate in EMSAs. In
contrast, the Rif1 C466A/C473A mutant exhibited a wild-type
pattern of retarded DNA species, binding DNA with similar
apparent afﬁnity to wild-type (Fig. 3d). These results show that
the potential Rif1 acceptor site C466/C473 for Pfa4-dependent S-
acylation and the HOOK domain’s DNA-binding site make
separate contributions to Rif1’s ability to effectively engage an
induced DSB, while the integrity of both sites is indispensable for
Rif1-mediated DNA end-protection and NHEJ.
Pfa4-dependent S-acylation of Rif1 C466 and C473 in vivo. To
address the possibility of Rif1 S-acylation at C466 and C473, we
turned to selective chemical labeling of thioester-linked cysteines.
First, we used acyl-biotin exchange (ABE) followed by bio-
chemical enrichment of S-acylated proteins. In brief, free
cysteines are blocked with N-ethylmaleimide (NEM) before
cysteine-acyl thioester cleavage using hydroxylamine (HA), with
subsequent biotinylation at reactivated cysteines, allowing the
capture of S-acylated proteins using avidin42 (Fig. 4a). This
procedure strongly enriched Rif1NTD from cell extracts in the
avidin fraction compared to control reactions with HA omitted
(Fig. 4b). Consistent with previous results33, deletion of PFA4
reduced the amount of Rif1NTD recovered by biotin-avidin afﬁ-
nity capture by ~5-fold. Importantly, capture of Rif1NTD C466A/
C473A from extracts of Pfa4-proﬁcient cells was more than 2-fold
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reduced compared to wild-type Rif1NTD (Fig. 4b). These ﬁndings
support NHEJ-critical Rif1 residues C466 and C473 as in vivo
Rif1 S-acylation sites.
We next devised an alternative method to more directly
establish Rif1 C466 and C473 S-acylation, which we term acyl-
carbamidomethyl exchange (ACE). Different from ABE chem-
istry, ACE replaces fatty acylation with carbamidomethyl (CAM)
rather than biotin and Rif1 is captured by immunoprecipitation,
such that modiﬁed peptides can be recovered, and S-acylation
sites are accessible for mapping using mass spectrometry (Fig. 4c).
For ACE, unmodiﬁed cysteines and tris (2-carboxyethyl)
phosphine (TCEP)-reduced cysteines (opening potential disulﬁde
bridges) were ﬁrst labeled with NEM. This procedure leaves
cysteine S-acylation intact (Supplementary Fig. 4a). Cysteine-acyl
thioesters were then cleaved by treatment with dithiothreitol
(DTT), followed by cysteine carbamidomethylation, allowing the
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identiﬁcation of S-palmitoylation sites in peptides with high
sensitivity (see Supplementary Fig. 4b, c). Immuno-precipitated
Rif1NTD was subjected to parallel reaction monitoring (PRM),
analyzing NEM and/or CAM-labeled C466 and C473 in tryptic
peptide fragments spanning residues 463 to 479. Peptides
containing NEM-labeled C466 and C473 were detected in wild-
type and pfa4Δ cells, accounting for unmodiﬁed Rif1NTD. Tryptic
fragments containing either CAM-labeled C466 or CAM-labeled
C473 were detected in wild-type cells, providing site-speciﬁc
evidence for Rif1 S-acylation in vivo (Fig. 4d). Under these
conditions, CAM-modiﬁed Rif1 peptides from pfa4Δ cells were
not detected (Fig. 4d, see also Supplementary Fig. 4 and
Supplementary Table 1 for further peptide analyses), supporting
the role of Pfa4 in Rif1 C466/C473 S-acylation. Alternative S-
acylation at C466 and C473 might explain why only combined
Rif1 C466A/C473A mutations result in defective NHEJ, suggest-
ing site redundancy for NHEJ-relevant S-acylation by Pfa4
in vivo.
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The PRM values for double NEM-modiﬁed Rif1 peptides
spanning residues 463 to 479 are ~10 times higher than the values
for peptides derived from Rif1 S-acylated at C466 or C473. This
implies that a substantial fraction of 15–20% of Rif1 was S-acylated
at either C466 or C473 in wild-type cells (Fig. 4d). DNA-damage
treatment with Zeocin did not lead to gross changes in Rif1 S-
acylation levels (Fig. 4e), consistent with constitutive Rif1 S-
acylation.
Rif1 S-acylation allows a nuclear-peripheral damage response.
To address the question how S-acylation may promote Rif1-
mediated NHEJ, we ﬁrst sought to determine whether the mod-
ifying enzyme, Pfa4, has access to the cell nucleus. Although
membrane associated, palmitoyl transferases have so far not been
observed at the inner nuclear membrane. Pfa4-GFP has been
localized at the endoplasmic reticulum (ER)43, which is con-
tinuous with the nuclear envelope, but inner nuclear membrane
access is selective, and whether Pfa4 can populate this sub-
compartment is unknown (Fig. 5a). Taking advantage of induced
inner nuclear membrane proliferation following overexpression
of nucleoporin Nup53, we asked whether Pfa4-GFP can access
the resulting, distinctive membrane structures. These intranuclear
lamellae have been shown to present in the form of so-called theta
(θ) nuclei with transecting membranes, providing the basis for a
quantiﬁable ﬂuorescence assay for testing inner nuclear mem-
brane localization of GFP-tagged candidate proteins44. As a
positive control, we expressed ER membrane protein Sec61-GFP,
which accessed the inner nuclear membrane, efﬁciently decorat-
ing θ structures44 induced by Nup53 overexpression (Fig. 5b). As
expected, cells expressing ER membrane protein Hrd1-GFP
showed ~4-fold lower levels of ﬂuorescent θ nuclei compared to
Sec61-GFP (Fig. 5c), reﬂecting poorer inner nuclear membrane
access44. Pfa4-GFP showed an intermediate phenotype, populat-
ing θ nuclei at ~1.5-fold lower levels than Sec61-GFP (Fig. 5c).
Upon DNA-damage treatment with Zeocin, the localization of
Sec61-GFP or Hrd1-GFP to θ structures did not change, while
Pfa4-GFP-associated θ structures increased ~2-fold (Fig. 5b, c).
These data show that Pfa4 localizes to the inner nuclear mem-
brane in unperturbed conditions, and this localization is
enhanced after DNA damage. Using cell fractionation, we con-
ﬁrmed previous results33 indicating Pfa4-dependent membrane
associations of Rif1, which proved partially dependent on Rif1
residues C466 and C473 (Supplementary Fig. 5). Together, these
Fig. 4 S-acylation of Rif1 C466 and C473 in vivo. a Outline of the ABE protocol, including protein alkylation at free cysteines with NEM, removal of S-acyl
groups including palmitoyl (Palm) using hydroxylamine (HA), and labeling with BMCC-biotin. Biotinylated proteins are captured on NeutrAvidin-coated
beads and the presence of Rif1NTD is analyzed by western blotting (WB). b Representative western blots of ABE assays performed with cells expressing
Myc-tagged Rif1NTD under control of a GAL1 promoter. Input: BMCC-biotin samples prior to biotin capture with and without HA. Input and AviF samples
were probed with anti-Myc and anti-biotin antibodies as indicated. Fold enrichment of Rif1NTD in AviF relative to wild-type is presented as mean
values ± s.e.m. (n= 3 independent experiments). c Outline of the ACE protocol, including treatment of proteins with TCEP (reducing potential disulﬁde
bridges between cysteine residues), alkylation at free cysteines with NEM, removal of S-acyl groups using DTT, and alkylation of freed-up cysteines with
chloroacetamide. Myc-tagged Rif1NTD is then immunoprecipitated for analysis by mass spectrometry (see Supplementary Fig. 4a for additional controls).
d Mass-spectrometric analysis of tryptic Rif1 fragments spanning amino acids 463 to 479. Following ACE, Rif1NTD tryptic peptides were subjected to
parallel reaction monitoring (PRM), measuring NEM (unmodiﬁed Rif1) and/or CAM-labeled (reﬂecting in vivo S-acylation) C466 and C473 in wild-type vs.
pfa4Δ. Integrated PRM counts are presented as mean values ± s.e.m. and were normalized using measurements of the ﬁve non-modiﬁed Rif1 peptides
shown on the right (see Supplementary Table 1 for additional information). Data are shown in logarithmic scale (n= 3 independent experiments).
e Measurements of C466/C473 NEM and/or CAM-labeled peptides (left panel) and unmodiﬁed control peptides (right panel) of Rif1 in untreated vs. Zeocin-
treated wild-type cells. PRM analysis of Rif1NTD peptides as in panel d. Mean values of integrated PRM counts ± s.e.m (n= 3 independent experiments) are
shown in logarithmic scale. See Supplementary Fig. 4b, c for peptide transitions used in the experiment. Source data are provided as a Source Data ﬁle
Untreated Zeocin
Nup53 overexpression
H
rd
1-
G
FP
Pf
a4
-G
FP
Se
c6
1-
G
FP
Nup53 overexpression
a b c
0.5
0
1.5
Th
et
a 
nu
cl
ei
 c
om
pa
re
d
to
 S
ec
61
-G
FP
Untreated
1
Zeocin
Se
c6
1-
G
FP
H
rd
1-
G
FP
Pf
a4
-G
FP
Se
c6
1-
G
FP
H
rd
1-
G
FP
Pf
a4
-G
FP
Nuclear pore
Pfa4
Access to nuclear
S-acylation targets
ER
Inner nuclear
membrane ?
Fig. 5 Pfa4 associates with the inner nuclear membrane. a Pfa4 localizes to the endoplasmic reticulum (ER)43 but access to the inner nuclear membrane
has not been demonstrated. b Cells with theta (θ) nuclei, induced by Nup53 overexpression-mediated inner nuclear membrane proliferation, were analyzed
for inner nuclear membrane-association of Sec61-GFP, Hrd1-GFP, and Pfa4-GFP (arrowheads indicate GFP-positive θ structures). Representative Z-
projections of confocal microscopy images are shown for cells treated or not with Zeocin. Scale bar: 5 μm. c Quantiﬁcation of the analysis shown in panel
b. Results from three independent experiments (n≥ 400 total cells per strain and condition) are shown as mean values ± s.e.m.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10349-z ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2535 | https://doi.org/10.1038/s41467-019-10349-z | www.nature.com/naturecommunications 7
results are consistent with Pfa4 having access to Rif1 in the
nucleus, where NHEJ-relevant S-acylation at C466 and C473 may
contribute to Rif1-membrane interactions.
To investigate whether S-acylation-mediated membrane
anchorage may direct the actions of Rif1 in NHEJ to the inner
nuclear membrane, we expressed ﬂuorescently tagged Rif1NTD,
which is unable to interact with Rap1 (ref. 2) and does not co-
localize with telomere clusters (Supplementary Fig. 6a). In
untreated conditions, we observed nuclear Rif1NTD-GFP foci in
~28% of wild-type cells. After DNA-damage treatment with
Zeocin or ionizing radiation (IR), focus formation was strongly
induced, reaching a peak ~30min post-treatment (Supplementary
Fig. 6b), when ~60% (Zeocin) and ~80% (IR) of cells exhibited
Rif1NTD-GFP foci (Fig. 6a, b and Supplementary Fig. 6c, d).
Moreover, while the majority of focus-positive cells in unper-
turbed conditions contained a single Rif1NTD-GFP focus, most
a
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focus-positive cells exhibited multiple (up to four) foci after DNA
damage treatment (Fig. 6c). DNA damage-induced Rif1NTD-GFP
foci were observed in G1 and S/G2 cells with no overt cell-cycle
dependence. DNA-damage treatment did not lead to increased
Rif1NTD expression levels (Supplementary Fig. 6e), suggesting
that focus formation reﬂected the redistribution of Rif1NTD-GFP
into foci upon DNA damage.
Next, we analyzed Rif1NTD-GFP foci in pfa4Δ cells. Untreated
cells were indistinguishable from wild-type with ~30% Rif1NTD-
GFP focus-positive cells, the majority of which contained a single
Rif1NTD-GFP focus (Fig. 6b, c and Supplementary Fig. 6c, d). In
contrast, the ability to form DNA damage-induced Rif1NTD-GFP
foci (~36% and ~38% focus-positive cells after Zeocin and IR,
respectively, see Fig. 6b and Supplementary Fig. 6d, f) and the
formation of multiple Rif1 foci in response to DNA damage
(Fig. 6c) was signiﬁcantly abrogated in pfa4Δ cells. Protein levels
of Rif1NTD remained unchanged upon loss of Pfa4 (Supplemen-
tary Fig. 6g). Importantly, in Pfa4-proﬁcient cells, introducing the
S-acylation mutation C466A/C473A also diminished the forma-
tion of DNA damage-induced Rif1NTD foci and the ability of cells
to form multiple Rif1 foci (Fig. 6b, c). Like S-acylation mutant
Rif1NTD C466A/C473A, the Rif1 HOOK DNA-binding mutant
was strongly compromised in its ability to form foci in response
to DNA-damage treatment (Fig. 6b, c). Combining the S-
acylation and HOOK mutations led to a more severe phenotype
compared to either the Rif1NTD C466A/C473A or the Rif1 HOOK
mutant (Fig. 6b, c). Thus, Pfa4-dependent S-acylation of Rif1 at
C466/C473 and the ability of Rif1 to bind DNA contribute to
effective Rif1 accumulation upon DNA damage.
To determine the sub-nuclear localization of Rif1NTD-GFP foci,
we scored their position relative to the nuclear envelope marked
by ﬂuorescently tagged nuclear-pore component Nup49 (ref. 45).
Dividing the nucleus into three concentric zones of equal area, we
found a strong bias of Rif1 accumulation in outermost zone 1, at
the nuclear periphery, in wild-type cells. Upon DNA damage,
~60% of Rif1NTD-GFP foci localized in zone 1 (Fig. 6d). While
cells expressing the Rif1 HOOK DNA-binding mutant main-
tained a strong localization bias to zone 1, cells with
compromised Rif1 S-acylation expressing Rif1NTD C466A/
C473A, Rif1NTD C466A/C473A HOOK, or wild-type Rif1NTD in
a pfa4Δ background, exhibited an increase in zone 2-localized foci
at the expense of zone 1-localized foci. Thus, Rif1 S-acylation
mutants display an apparent reduction in Rif1-inner nuclear
membrane interactions in conjunction with a signiﬁcant impair-
ment in the formation of DNA damage-induced Rif1-foci
observed in all mutant backgrounds tested (Fig. 6b, c and
Supplementary Fig. 6c, d, f).
Taken together, these data are consistent with a model where
enrichment of Rif1 at the inner nuclear membrane mediated by
Pfa4-dependent S-acylation of C466/C473 and its intrinsic DNA-
binding activity enable effective Rif1 accumulation at nuclear-
peripheral DNA damage, promoting preferential repair of
membrane-proximal DSBs along the NHEJ pathway (Fig. 7).
Discussion
Here, we show that the palmitoyl transferase Pfa4 is essential for
Rif1-dependent DSB repair by NHEJ. Loss of Pfa4 caused a drop
in NHEJ efﬁciency but did not exacerbate the NHEJ defect of
rif1Δ cells, genetically implicating Pfa4 and Rif1 in a common
DSB repair pathway (Fig. 1). Starting from a structure-guided
approach, we identiﬁed Rif1 C466 and C473 as two cysteine
residues required for efﬁcient NHEJ in vivo (Fig. 2), accumulation
of Rif1 at DSBs, and attenuation of DNA end-resection (Fig. 3).
We demonstrate that C466 or C473 are modiﬁed by S-acylation
in vivo in a strictly Pfa4-dependent manner, strongly suggesting
they are direct Pfa4 S-palmitoylation targets (Fig. 4). Residual
avidin-enrichment after subjecting Rif1NTD C466A/C473A to
ABE chemistry points to Rif1 S-acylation at additional, as-yet
unmapped sites (Fig. 4b). While these potential additional sites
are neither required nor sufﬁcient for Rif1 to promote NHEJ, at
least one Pfa4-dependent S-acylation event at C466 or C473 is
essential for Rif1-mediated NHEJ (Fig. 2). Localizing to the inner
nuclear membrane (Fig. 5), Pfa4 has access to nuclear Rif1 and
promotes Rif1-membrane associations33 (Supplementary Fig. 5).
Furthermore, we discovered the nuclear-peripheral, focal accu-
mulation of Rif1NTD in response to treatment of cells with
radiomimetic drug Zeocin or IR. This localized DNA-damage
response of Rif1 occurred in cells in G1 and S phase of the cell
cycle, and thus reﬂects a cell-cycle phase-independent process.
Importantly, DNA damage-induced Rif1 focus formation was
dependent on Pfa4, S-acylated Rif1 residues C466 and C473, and
required Rif1’s DNA-binding activity (Fig. 6). As IR and Zeocin
give rise to DSBs and ssDNA breaks, we cannot exclude the
possibility that Rif1 responds to multiple types of DNA damage.
However, Rif1 accumulates at endonuclease-induced DSBs in a
Pfa4 and C466/C473-dependent manner to attenuate DNA end-
resection and promote NHEJ (Fig. 3 and Supplementary Fig. 3a).
We therefore propose that the focal accumulation of Rif1 at the
nuclear periphery, induced by Zeocin or IR, is a direct reﬂection
of DSB binding. This contrasts with HR-dependent DSB repair
foci marked by Rad52, which are generally found within the
nuclear lumen46, a compartment that was deprived of DNA
damage-induced Rif1 foci. Based on our results, we suggest a
model where posttranslational fatty acylation at C466 or C473
increases the afﬁnity of Rif1 for the inner nuclear membrane,
creating a nuclear-peripheral compartment of high local Rif1
concentration. Here, Rif1 is poised to mount an effective response
Fig. 6 Rif1 C466/C473 S-acylation mediates a peripheral DNA damage response. a Confocal microscopy of cells expressing Rif1NTD-GFP and Nup49-Ruby2,
untreated or treated with Zeocin (100 μg/ml, 30min; see Supplementary Fig. 6c, d for IR treatment). Z-projected images of cells in the indicated cell cycle
phases, illustrating the observed classes of focus-negative and Rif1NTD focus-positive (1–4 foci) cells. For untreated cells, only the main class (focus-negative,
representing ~75% of cells) is shown. Scale bar: 5 μm. b Quantiﬁcation of focus-positive and focus-negative cells for the indicated strains expressing wild-
type or mutant Rif1NTD-GFP, treated or not with Zeocin. Results of three independent experiments (n≥ 100 cells per experiment) are presented as mean
values ± s.e.m. For statistical analysis of GFP-positive cells treated or not with Zeocin, one-way Anova and a post-hoc Tukey–Kramer multiple comparison
test was performed, comparing wild-type to mutants. c Quantitation of Rif1NTD-GFP foci per cell for the indicated strains with and without DNA-damage
treatment (Zeocin, IR). Violin plots show data from three independent experiments (n≥ 95 cells per strain and condition), binned for number of foci per cell.
The average number of foci per cell (± s.e.m.) and the fraction of cells with ≥2 foci (± s.e.m.) are indicated. For statistical analysis, comparing wild-type to the
indicated mutants with and without DNA-damage treatment, one-way Anova and a post-hoc Tukey–Kramer multiple comparison test was performed;
unpaired t-test for cells treated or not with IR. d Zoning assay scoring the position of Rif1NTD-GFP foci in the indicated strains treated with Zeocin relative to
the nuclear envelope (marked by Nup49-Ruby2). Foci were binned in three concentric zones of equal area; dashed line at 33% indicates random distribution.
Results of three independent experiments (n= 50 Rif1 foci from 50 focus-positive cells per strain per experiment) are presented as mean values ± s.e.m. For
statistical analysis, one-way Anova and a post-hoc Tukey–Kramer multiple comparison test was performed. Nuclear zones in wild-type were compared to
the corresponding zones in the indicated mutants. See also Supplementary Fig. 6. Source data are provided as a Source Data ﬁle
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to DNA damage, encapsulating DSBs with its HOOK domain,
and dampening DNA end-resection to favor repair by NHEJ
(Fig. 7).
It is tempting to speculate that membrane binding may provide
Rif1 with additional means of promoting favorable DNA repair
outcomes, for example by constraining the movement of DSB
ends to suppress chromosome instability by ectopic recombina-
tion events. At the same time, membrane-attachment could allow
Rif1 to harness the nuclear envelope as a scaffold to facilitate the
coordination of DSB ends for re-ligation. For telomere main-
tenance, Rif1 S-acylation appears to be dispensable33, and this may
be explained by the recruitment of Rif1 to telomeres through
protein-protein interactions with Rap1 (ref. 2). However, S-acy-
lation may strengthen telomere interactions at the nuclear per-
iphery to reinforce the telomere position effect33, where Rif1 helps
antagonize transcriptional silencing near telomeres47,48. Rif1
interactions with the nuclear envelope have also been implicated
in chromatin architecture and DNA replication5,7,14,15,49,50. While
the ability of Rif1 to suppress DNA replication origin ﬁring does
not depend on Pfa4 (ref. 8) or C466 and C473 (Supplementary
Fig. 3c), it will be important to explore at high resolution whether
Rif1 S-acylation mutants act at ectopic genomic sites to determine
whether fatty acylation modulates replication timing programs in
eukaryotes.
The link between Rif1 and nuclear-peripheral DNA repair
described herein resonates with increasing evidence for DNA repair
compartmentalization and the impact of DSB microenvironments
on repair pathway choice across organisms51,52. In human cells,
nuclear-peripheral DSBs bound at the proteinaceous nuclear lamina
are preferentially repaired by NHEJ53. The compaction of silent
heterochromatin and repetitive sequence elements in lamina-
associated domains has been proposed to hamper the recruitment
of HR proteins, leading to a local NHEJ bias53. Reported lamina
interactions of Rif1 (refs. 5,7,49) raise the interesting possibility that
peripheral sequestration of Rif1 might have a role in sub-nuclear
compartments geared towards NHEJ in mammalian cells. Of note,
mammalian Rif1 S-palmitoylation is predicted by Swisspalm/CSS-
Palm41, but it remains to be determined whether these modiﬁcations
occur in vivo and how they might relate to NHEJ. In yeast, S-
acylated Rif1 may preferentially target DSBs for NHEJ in nuclear
envelope-associated heterochromatin or near telomeres. Further-
more, persistent DSBs in yeast relocate to the nuclear periphery54–56,
which may facilitate access by S-acylated Rif1.
Protein S-acylation has been detected on a wide range of
cytosolic and nuclear proteins31,57, and dysfunctional fatty acy-
lation has been implicated in human diseases including
cancer58,59. However, the functional consequences for most tar-
gets of S-acylation remain to be determined. Interestingly, che-
mical inhibition of protein S-palmitoylation in mammalian cells
led to a muted DNA-damage response60. Here, we uncover a role
for protein S-acylation in DSB repair pathway choice. The
reversible nature of S-palmitoylation is reminiscent of well-
established posttranslational modiﬁcations with important roles
in DSB repair, including protein phosphorylation and ubiquiti-
nation, potentially allowing the dynamic regulation of Rif1 at
DNA damage. The essential requirement for S-acylation in Rif1-
mediated NHEJ provides the ﬁrst example of a direct involvement
of fatty acylation in DNA repair.
Methods
Yeast techniques. The complete list of S. cerevisiae strains used in this study can
be found in Supplementary Table 2. Deletions and epitope tagging of genes of
interest were done by one-step PCR gene replacement61. Point mutations in the
RIF1 gene were introduced using delitto perfetto62 and/or CRISPR/Cas9-based
methods63 (see Supplementary Table 3 for primer sequences). For overexpression
of Myc-tagged Rif1NTD, Pfa4-GFP, and Nup53, a GAL1 galactose-inducible pro-
moter was inserted genomically and expression was induced by addition of 2% (w/
v) galactose (Formedium, GAL02) to cells cultured in YPLG. For drop assays,
strains were grown exponentially, and serial 10-fold dilutions were spotted on
YPAD agar plates before incubation at the indicated temperatures as described
previously12. Plates were imaged after 2 to 3 days.
NHEJ assays. The efﬁciency of NHEJ as measured by cell survival was determined
as described38,64. JKM179-derived strains (see Supplementary Table 2) were grown
overnight in YPAD, then diluted in YPLG and grown exponentially. For transient
HO-endonuclease expression, 2% (w/v) galactose was added to the culture med-
ium. At the indicated time-points, cells were plated on glucose-containing YPAD
agar plates. Control cells were removed prior to HO-endonuclease induction and
plated on medium containing glucose. HO endonuclease cut-efﬁciency was rou-
tinely determined by qPCR (see Supplementary Table 3 for primer sequences) and
data was normalized accordingly3. Colonies were counted 3 days after plating, and
NHEJ efﬁciency was calculated as described64.
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Fig. 7 Rif1 S-acylation mediates nuclear-peripheral DSB repair pathway choice. Pfa4-dependent S-acylation of Rif1 provides membrane anchors and governs
localization of Rif1 to the inner nuclear membrane. Telomeres are tethered to the nuclear envelope by Rif1-independent mechanisms (dashed lines) and
Pfa4 is dispensable for telomere homeostasis. In contrast, Pfa4-dependent Rif1 S-acylation at residues C466 or C473 (depicted as a zig-zag line) is
essential for Rif1-mediated NHEJ. We propose that the increased local concentration of S-acylated Rif1 in proximity of the inner nuclear membrane
generates a nuclear-peripheral compartment in which Rif1 is effective in promoting DSB repair by NHEJ
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Determination of cell viability in the presence of Zeocin. The plating efﬁciency
of each strain was determined on drug-free medium. Exponentially growing cells
were diluted appropriately and plated on YPAD medium containing 70 μg/ml
Zeocin (ThermoFisher Scientiﬁc, R25001). Colony outgrowth was quantiﬁed after
incubation for 3–4 days at 30 °C. Zeocin resistance relative to wild-type cells was
determined as described3.
Quantiﬁcation of ssDNA as a measure of DNA end-resection. Quantiﬁcation of
ssDNA was done as described previously3. In brief, genomic DNA was extracted
using a phenol:chloroform and propan-2-ol method, then digested overnight with
AluI (New England Biolabs, R01137L). qPCR was performed using GoTaq qPCR
Master Mix (Promega, A6001). To detect the formation of ssDNA, primer pairs
ﬂanking AluI sites in the proximity of an HO endonuclease-induced DSB were used.
AluI sites that have been converted to ssDNA by end-resection are resistant to
cleavage, leading to increased qPCR yield40. To normalize the data, qPCR ampliﬁ-
cations of genomic regions devoid of AluI sites (located at the SMC2 locus) were
performed. qPCR reactions were carried out to assess the efﬁciency of DSB-induction
by the HO endonuclease. Primer sequences are reported in Supplementary Table 3.
Western blotting. Western blots were performed as described12, using the following
primary antibodies: mouse monoclonal anti-beta actin (Abcam, ab8224, RRID:
AB_449644, 1:1000 dilution), rat monoclonal anti-tubulin (Abcam, ab6161, RRID:
AB_305329, 1:4000 dilution), mouse monoclonal anti-Pgk1 (Abcam, ab113687,
RRID: AB_10861977, 1:5000 dilution), rabbit polyclonal anti-biotin (Abcam, ab1227,
RRID: AB_298990, 1:3000 dilution), mouse monoclonal anti-c-Myc (clone 9E10,
Sigma-Aldrich, M4439, RRID: AB_439694, 1:4000 dilution), mouse monoclonal anti-
nuclear pore complex proteins (Mab414, Abcam, ab24609, RRID: AB_448181, 1:5000
dilution). Secondary antibodies used were goat anti-rat IgG (Abcam, ab97057, RRID:
AB_10680316, 1:10,000 dilution), donkey anti-rabbit IgG (GE Healthcare, GENA934,
RRID: AB_2722659, 1:10,000 dilution) and sheep anti-mouse IgG (GE Healthcare,
NA931, RRID: AB_772210, 1:10,000 dilution). See “Quantiﬁcation and statistical
analysis” for a detailed description of western blot quantiﬁcations.
ChIP assays. To detect enrichment of proteins in proximity of the HO-endonuclease
cut-site at the MATα locus, cells were grown logarithmically in YPLG medium and
the HO endonuclease was then induced by adding 2% (w/v) galactose. ChIP was
performed as reported previously3 (see Supplementary Table 3 for primer sequences).
Rif1NTD protein puriﬁcation. pFastBac-derived constructs of the wild-type and
mutant S. cerevisiae Rif1 N-terminal domain spanning residues 100–1322 were
expressed as N-terminal Strep(II)-tag fusions in Trichoplusia ni High Five insect
cells (ThermoFisher Scientiﬁc, B85502). Bacmids, primary and secondary viruses
were produced using the Bac-to-Bac baculovirus expression system (ThermoFisher
Scientiﬁc, 10359–016) and Spodoptera frugiperda (Sf9) insect cells (ThermoFisher
Scientiﬁc, 11496015), as described previously3. Insect cell expression cultures of
Rif1NTD (residues 100–1322) and Rif1NTD mutants (HOOK DNA-binding mutant:
K437E/K563E/K570E; S-acylation mutant: C466A/C473A) were grown in SF900-II
medium (ThermoFisher Scientiﬁc, 10902096) at 27 °C and infected at a cell density
of 4 × 106 ml with 15 ml/l of P2 virus solution. Cells were harvested by cen-
trifugation 48 h after infection and lysed by sonication in 50 mM Tris-HCl pH 8.0,
500 mM NaCl, 1 mM TCEP, 1 mM PMSF, 5 mM 2-mercaptoethanol, and protease-
inhibitor cocktail (Sigma, S8830–20TAB). After clariﬁcation by ultracentrifugation
(45,000×g for 45 min at 4 °C), Rif1NTD was afﬁnity-extracted using Strep-Tactin
sepharose beads (IBA, 2–1201–010). The protein solution was concentrated by
ultraﬁltration (Amicon Ultra-15 centrifugal ﬁlter unit, 30 KDa cutoff, Merck,
UFC903024) and separated by size exclusion chromatography using HiLoad 26/
600 Superdex 200 pg (GE Healthcare, 28989336) in 50 mM HEPES pH 7.4,
310 mM NaCl, 1 mM TCEP. Puriﬁed Rif1NTD was concentrated by ultraﬁltration
once again, ﬂash-frozen in liquid nitrogen, and stored at −80 °C.
DNA-binding assays. The double-stranded DNA substrate for Rif1 EMSAs3 was
assembled from polyacrylamide gel electrophoresis (PAGE)-puriﬁed oligonucleo-
tides EMSA1 and EMSA2 (Microsynth AG, see Supplementary Table 3 for
sequences). EMSA1 was labeled using T4 polynucleotide kinase (New England
BioLabs, M0201L) and [γ-32P] ATP (Hartmann Analytic, SRP-301) at 37 °C for
1 h. The reaction was stopped by adding 20 mM EDTA and EMSA1 was puriﬁed
using an Illustra MicroSpin G-25 column (GE Healthcare, 27532501) into 10 mM
Tris-HCl pH 8.0, 1 mM MgCl2, 50 mM NaCl. EMSA 1 and 2 were mixed at 2 µM
concentration and annealed (in 10 mM Tris-HCl pH 8, 1 mM MgCl2, 50 mM
NaCl) by heating for 5 min to 98 °C and cooling at 1 °C/min to 4 °C. The annealed
DNA substrates (20 µl) was puriﬁed by 14% PAGE electrophoresis as described65
and stored at 4 °C in 10 mM Tris-HCl pH 8.0, 1 mM EDTA. Rif1NTD protein
concentrations were measured using the Bradford method with a bovine serum
albumin (BSA) standard. EMSAs were performed as described previously3. In brief,
the labeled DNA substrate at a ﬁnal concentration of 1 nM was added to serially
diluted protein to obtain the protein concentrations indicated (10–160 nM) in a
buffer containing 20 mM Tris-HCl pH 8.0, 100 mM NaCl, 2.5 mM MgCl2, 10 mM
CaCl2, 0.1 mg/ml BSA, 1 mM TCEP. The mixture was incubated for 30 min at
20 °C before adding glycerol at a ﬁnal concentration of 8% (v/v), and separating a
10-µl sample by 1.2% agarose gel electrophoresis at 150 V for 2 h, in 0.5× TBE at
4 °C. Gels were dried on DE81 Whatman chromatography paper (Sigma-Aldrich,
Z286591), exposed to storage phosphor screens (BioRad, 1707843), scanned by a
Typhoon phosphorimager, and quantiﬁed as reported below in section “Quanti-
ﬁcation and statistical analysis”.
Acyl-biotin exchange (ABE). Substitution of thioester-linked lipid modiﬁcations
on cysteines with biotin was performed according to published protocols33,42.
Brieﬂy, Myc-tagged Rif1NTD was expressed from a GAL1 promoter for 20 h by
adding 2% (w/v) galactose to cell cultures in exponential growth phase. Cells from
100–200 ml cell culture were pelleted and lysed by bead-beating in lysis buffer (50
mM Tris-HCl pH 7.5, 150 mM KCl, 5 mM EDTA, 6M urea) containing 50 mM N-
ethylmaleimide (NEM, ThermoFisher Scientiﬁc, 23030) and protease inhibitors
cocktail (Roche, 05 892 791 001). Triton X-100 was added to a ﬁnal concentration
of 0.5% to the cleared lysates, and free cysteines were blocked with NEM for 2 h at
4 °C on a rotating wheel. After chloroform-methanol precipitation, proteins were
solubilized in resuspension buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 2%
SDS, 8M urea). Following addition of 1-biotinamido-4-[4’-(maleimidomethyl)
cyclohexanecarboxamido]butane-biotin (BMCC-biotin, ThermoFisher Scientiﬁc,
21900) buffer (50 mM Tris-HCl pH 7.5, 300 μM BMCC-biotin, 1x PBS), samples
were split and hydroxylamine (HA, Sigma-Aldrich, 438227) was added (+HA) or
not (-HA) to a ﬁnal concentration of 1M. Biotin exchange was performed for 2 h at
4 °C. After precipitation and solubilization, NeutrAvidin agarose beads (Thermo-
Fisher Scientiﬁc, 29201) in 50 mM Tris-HCl pH 7.5, 5 mM EDTA, 0.1% Triton X-
100 were added. Capture of biotinylated proteins (Avidin fraction, AviF) was
performed overnight at 4 °C. Beads were washed with 1x PBS containing 0.5 M
NaCl and 0.1% Triton X-100. For western blotting, resuspension buffer and 4x
non-reducing sample buffer (240 mM Tris-HCl pH 8, 8% SDS, 40% glycerol, 0.02%
bromophenol blue) were added and protein samples were boiled before SDS-
PAGE. Aliquots of the +HA and -HA input fractions (prior to Avidin-capture)
were used as loading controls and for normalization. See “Quantiﬁcation and
statistical analysis” for a detailed description of ABE quantiﬁcation.
Acyl-carbamidomethyl exchange (ACE). Myc-tagged Rif1NTD expression and cell
lysis was performed as described for ABE chemistry, with the exception that the lysis
buffer contained 10mM Tris(2-carboxyethyl)phosphine hydrochloride (TCEP, Fluka,
93284). TCEP was used to reduce disulﬁde bridges formed by closely-spaced cysteine
residues, leaving S-acylation intact66 (see also Supplementary Fig. 4). Final con-
centrations of 50mM NEM and 0.5% Triton X-100 were added to the cleared lysates,
and blocking of reactive cysteines was performed for 2 h at 4 °C on a rotating wheel.
Chloroform-methanol precipitates were solubilized in resuspension buffer (50mM
Tris-HCl pH 7.5, 100mM NaCl, 2% SDS, 8M urea). Removal of S-acyl groups from
cysteines was achieved by incubating the samples with beads buffer (50mM Tris-HCl
pH 7.5, 5 mM EDTA, 0.1% Triton X-100) containing 10mM 1,4-dithiothreitol (DTT,
Sigma-Aldrich, 43815) for 1 h at room temperature. Proteins were precipitated,
resuspended, and beads buffer containing 20mM 2-chloroacetamide (CAA, Sigma-
Aldrich, 22790) was added, allowing CAM-labeling of freed-up cysteines. Myc-tagged
Rif1NTD immunoprecipitation was performed overnight at 4 °C by addition of pre-
washed anti-Myc-coupled magnetic agarose beads (Chromotek, ytma-20). After
extensive washing with high (50mM Tris-HCl pH 7.5, 500mM NaCl) and low salt
(50mM Tris-HCl pH 7.5, 150mM NaCl) buffers, samples were subjected to tryptic
digestion on beads and analyzed by mass-spectrometry.
ACE and acyl-N-ethylmaleimide exchange on synthetic peptides. Synthetic
peptides designed on the tryptic Rif1 peptide spanning residues 463–479 were
obtained from ThermoFisher Scientiﬁc, and contained palmitoylated C466/CAM-
labeled C473 (IYQC[PALMITOYL]IMLSPVC[CAM]ETIPEK), CAM-labeled
C466/palmitoylated C473 (IYQC[CAM]IMLSPVC[PALMITOYL]ETIPEK) or
palmitoylated C466/ palmitoylated C473 (IYQC[PALMITOYL]IMLSPVC[PAL-
MITOYL]ETIPEK). Peptides were diluted in 20% CH3CN, aliquoted, and stored at
−20 °C. To monitor acyl-CAM and acyl-NEM exchange following treatment with
reducing agents, peptide aliquots were diluted in a solution containing 50 mM Tris-
HCl pH 8, 40% CH3CN, and either 40 mM DTT or 40 mM TCEP, and reduction
was carried out for 2 h at 56 °C. Alkylation with either 90 mM iodoacetamide (IAA,
Sigma-Aldrich, I1149) or 90 mM NEM was performed for 1 h at room tempera-
ture. 1% triﬂuoroacetic acid (TFA, Pierce Perbio, 28904) was added, and samples
were analyzed by mass spectrometry.
Mass spectrometric analysis of synthetic peptides. Synthetic peptides were
analyzed by capillary liquid chromatography tandem mass spectrometry (LC-MS).
Peptides were loaded in 0.1% formic acid (Pierce Perbio, 28905), 10% acetonitrile
(VWR, 83640.290) in water (Sigma Aldrich, 14263–1 l) onto a 75 μm×15 cm ES811
column (Accucore C4, 2.6 μm, 150 Å) at a constant pressure of 800 bar, using an
EASY-nLC 1000 liquid chromatograph with one-column set up (Thermo Scien-
tiﬁc). Peptides were separated at a ﬂow rate of 300 nl/min with a linear gradient of
10–60% buffer B in buffer A in 10 min, followed by a linear increase from 60 to
90% over 1 min, and the column was ﬁnally washed for 5 min at 90% buffer B
(buffer A: 0.1% formic acid, 10% acetonitrile in water; buffer B: 0.1% formic acid in
acetonitrile). The column was mounted on a DPV ion source (New Objective)
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connected to an Orbitrap Fusion mass spectrometer (Thermo Scientiﬁc), data were
acquired using 120,000 resolution, and MS1 signals were quantiﬁed using Skyline
4.1 (ref. 67) to generate the results of Supplementary Fig. 4a.
PRM data acquisition. To increase sensitivity and speciﬁcity for the analysis of the
biological material (Fig. 4), PRM analyses were performed using the LC-MS system
described above, but with a 50 μm×15 cm ES801 column (C18, 2 μm, 100 Å) and a
linear gradient of 2–6% buffer B in buffer A in 2min, followed by an linear increase
from 6 to 30% in 30min, 30–50% in 10min, 50–80% in 1min, and ﬁnally the column
was washed for 13min at 80% buffer B at a ﬂow rate of 150 nl/min. One MS spectrum
at 120,000 resolution was acquired from 400–1200 Da, followed by 9 PRM spectra as
described in Supplementary Table 1. An isolation window of 1.6 Da, a resolution of
120,000, and an automatic gain control value of 5e4 was used. Fragmentation was
performed with a higher energy collision dissociation (HCD) collision energy of
30 eV, and MS/MS scans were acquired with a scan range of 100–2000Da with a
resolution of 120,000. Five non-modiﬁed peptides were selected from a data-
dependent analysis using MASCOT for identiﬁcation and Scaffold for validation (see
below). These peptides were used as loading controls and for normalization of the
three modiﬁed peptides, and are listed in Supplementary Table 1.
PRM data analysis. PRM data were processed using Skyline 4.1 (ref. 67). The
transition selection was systematically veriﬁed and adjusted when necessary to
ensure that no co-eluting contaminant distorted quantiﬁcation, based on traces co-
elution (retention time), and the correlation between the relative intensities of the
endogenous fragment ion traces and their counterparts from the library. Further
calculations and ﬁgures were based on total integrated PRM intensities of the
selected transitions (see Supplementary Fig. 4b, c). Mascot v. 2.5 (Matrix Science
Ltd.) was used in the Decoy mode to search the Swissprot yeast version 2017_04
including common contaminants. The enzyme speciﬁcity was set to trypsin,
allowing for up to one incomplete cleavage site. Modiﬁcation of cysteines with
carbamidomethyl (CAM;+ 57.0245 Da), N-ethylmaleimide (NEM; +125.0477 Da),
oxidation of methionine (+15.9949 Da), and acetylation of the protein N-terminus
(+42.0106 Da) were set as variable modiﬁcations. Parent ion mass tolerance was set
to 5 ppm and fragment ion mass tolerance to 0.01 Da. The results were validated
with the program Scaffold Version 4.6.2 (Proteome Software, Portland, USA).
Peptide identiﬁcation was accepted if established at less than 0.1% false discovery
rate, as calculated in Scaffold.
Subcellular fractionation. Assessment of solubility of Myc-tagged Rif1NTD in
wild-type or mutant strains was performed by differential centrifugation as
reported33. Exponentially growing cells were collected, spheroblasted, and resus-
pended in 100 mM KCl, 50 mM HEPES-KOH pH 7.5, 2.5 mM MgCl2, and 0.4 M
sorbitol. After centrifugation (1500×g for 1 min at 4 °C), pellets were resuspended
in an equal volume of extraction buffer (100 mM KCl, 50 mM HEPES-KOH pH
7.5, 2.5 mM MgCl2, 50 mM NaF, 5 mM Na4P2O7, 0.1 mM NaVO3, protease inhi-
bitors). Spheroblasts were lysed on ice by addition of 0.25% Triton X-100, and the
whole cell extract fraction was collected. Lysates were underlayered with half a
volume of 30% sucrose, and centrifuged at 13,500×g for 10 min at 4 °C. Pellets,
corresponding to the membrane-bound fraction, and soluble fraction were sepa-
rated. Equal amounts of protein were loaded on 3–7% Tris-acetate gels. See
“Quantiﬁcation and statistical analysis” for a detailed description of the quantiﬁ-
cation of Rif1NTD enrichment in the soluble and membrane-bound fraction.
Spinning-disk confocal microscopy. Exponentially growing cells, cultured in
sterile-ﬁltered YPAD, were treated with 100 μg/ml Zeocin for 30 min or 100 Gy of
IR in a Cellrad X-ray irradiator (Faxitron). Aliquots were taken before treatment
and at deﬁned time-points after treatment, and cells were collected by cen-
trifugation and ﬁxed with 4% paraformaldehyde at room temperature. Nuclear
staining was done with 100 ng/ml DAPI (Sigma-Aldrich, D9542) in 1x PBS. To
assess protein localization to the inner nuclear membrane, θ nuclei that arise from
Nup53 overexpression were scored as described previously44. Brieﬂy, exponentially
growing cells in sterile-ﬁltered YPLG were induced to overexpress Nup53 and/or
Pfa4-GFP by addition of 2% (w/v) galactose for 20 h and θ nuclei were quantiﬁed
and expressed relative to a Sec61-GFP positive control. Images were acquired using
an Olympus IX81 spinning disk ﬂuorescence confocal microscope equipped with a
Yokogawa CSU-X1 scan head, a 2X back-illuminated EM-CCD EvolveDelta
camera (Photometrics), an XY-motorized ASI MS-2000 Z-piezo stage, and a Pla-
nApo x100, NA 1.45 oil objective. Fluorophores were excited at 561 nm (RFP and
Ruby2), 491 nm (GFP), 445 nm (CFP), and 405 nm (DAPI). Z-stacks were col-
lected with 100–300 ms exposures, with 40 slices at 0.25 μm intervals. Images were
collected using Visiview v. 3.0 (Vistron systems GmbH), deconvolved using
Huygens Remote Manager where necessary, and channel-aligned using Huygens
Professional. Image analysis was performed using Fiji software68. Zoning assays
were performed as described previously45 using the Pointpicker ImageJ plugin,
binning cells with single Rif1NTD-GFP foci localized on the focal plane containing
the largest nuclear outline marked by Nup49-Ruby2.
Quantiﬁcation and statistical analysis. Statistical analyses were performed using
GraphPad Prism v. 7. The applied tests and number of independent observations
are indicated in the corresponding ﬁgure legends. Western blot band intensities
were quantiﬁed using Fiji software68, and normalized using the indicated loading
controls. Results shown in Supplementary Figs. 1a, 2c, 3b, 6e, and 6g were plotted
with GraphPad Prism v. 7. Western blot signals for biotin-captured Rif1NTD (AviF)
were quantiﬁed using Fiji software68. Band intensities were background-corrected
by subtraction of the signal obtained in the AviF without HA and normalized to the
input for data shown in Fig. 4b. Western blot signals for Rif1-enrichment in soluble
or membrane fractions were quantiﬁed using Fiji software68. Band intensities were
background-corrected and normalized to tubulin for the soluble fraction and to the
nuclear pore p90 band for the membrane-bound fraction. Results are shown in
Supplementary Fig. 5. Scanned EMSA phosphorimages were analyzed with Ima-
geJ69. Total intensity of each individual lane was plotted and separated into the
unbound DNA signal and the retarded DNA signal. The percentage of retarded
DNA signal including all shifted bands (deﬁned as “fraction bound”) was analyzed
and plotted using GraphPad Prism v. 7 to produce the results shown in Fig. 3d. For
quantitation of θ nuclei and Rif1NTD-GFP foci presented in Figs. 5 and 6,
respectively, confocal microscopy images were analyzed using Fiji software68.
Violin plots shown in Fig. 6c were generated with Rstudio.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
A reporting summary for this article is available as a Supplementary Information ﬁle. The
data underlying Figs. 1b–d, 2c, 3a, b, d, 4d, e, and 6b, c are provided as a Source Data ﬁle.
All data supporting the ﬁndings of this study are available from the corresponding author
upon reasonable request. Structural ﬁgures were prepared with PyMOL v. 1.8.4
(Schrödinger Inc.) and are based on published structures (PDB: 5NVR and PDB:
5NW5)3. The mass spectrometry proteomics data have been deposited at
ProteomeXchange via PRIDE70 and can be accessed using access code PXD012137.
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